| abstract |
The present invention provides compounds having formula (I) or (II): Formula (I), Formula (II) and pharmaceutically acceptable derivatives thereof, wherein m, p, R 1 , R 2 , R 3 and R 4 are generally and as described in classes and subclasses in the present invention, and in addition are related to their pharmaceutical compositions and the activity of HGF / SF or other cytokines It provides its use for the treatment of any of a number of diseases, disorders or diseases. The present invention is directed to novel therapeutic agents that can mimic or modulate the activity of various cytokines or that can provide at least one or more of the same biological activities as the previous exemplary non-limiting cytokines. |